Next Article in Journal
Overcoming Trastuzumab–Pertuzumab Resistance and Optimizing Sequential Anti-HER2 Therapy in HER2-Positive Metastatic Breast Cancer
Previous Article in Journal
Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab
Previous Article in Special Issue
Comment on Santana-Bejarano et al. NRP1 and GFAP Expression in the Medulloblastoma Microenvironment: Implications for Angiogenesis and Tumor Progression. Cancers 2025, 17, 2417
 
 
Reply

Article Versions Notes

Cancers 2026, 18(6), 931; https://doi.org/10.3390/cancers18060931
Action Date Notes Link
article html file updated 13 March 2026 06:49 CET Original file https://www.mdpi.com/2072-6694/18/6/931/html
article pdf uploaded. 13 March 2026 06:48 CET Version of Record https://www.mdpi.com/2072-6694/18/6/931/pdf
article xml uploaded. 13 March 2026 06:48 CET Update https://www.mdpi.com/2072-6694/18/6/931/xml
article xml file uploaded 13 March 2026 06:48 CET Original file -
Back to TopTop